Neogen acquires Colitag water microbiology testing

Neogen (NASDAQ: NEOG) announced that it has acquired Clarus Labs, Inc the owner of the patented Colitag™ water test. The acquisition provides Neogen greater access to the $400 million global water microbiology testing market. Colitag™ test, detects coliform bacteria, including E. coli, in water. Colitag also detects coliforms that have been weakened, but not killed. From 2004 Neogen has offered Colitag to the food and beverage industries in the United States and Canada through a distribution agreement. Now Neogen will own the technology and will work with a sister company to distribute the technology to markets outside of its traditional markets of foods. @
Neogen acquires water microbiology testing technology

LANSING, Mich., Aug. 1, 2018 /PRNewswire/ — Neogen Corporation (NASDAQ: NEOG) announced today that it has acquired Clarus Labs, Inc. The acquisition provides…

No comments

Leave a Reply